Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications consumer willingness pay “second generation” genetically engineered products role
… analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate … and transparent model Developing documents and publications to communicate the value of your product …
… for IPAY 2027 The names of the drugs selected for the second cycle of Medicare drug price negotiations (DPNs) will … and evidence they can submit in support of their products, should they be chosen. In a previous post , we … how the optional elements in Section I have changed in the second negotiation cycle (IPAY 2027). See Table 1 at the end …
… Data and Real-World-Evidence for Drug and Biological Products Share on: October 10, 2023 In response to the 21st …
… our client to understand outcomes following first- and second-line therapy, identified or validated prognostic risk … settings. In addition to providing the basis for multiple publications and presentations, these findings contribute …
Literature Reviews and Meta-analyses We conduct literature reviews and meta-analyses using the most rigorous methodologies, so you get reliable and reproducible answers to your research questions. High-quality literature reviews can help you understand: …
… Analysis As a pharmaceutical or device manufacturer, your products have different attributes related to safety, … mode of administration, etc. and so do your competitor’s products—but, do you know which of those attributes matter …
… the recommended genetic testing in this population. Publications: Bhandari NR, Hess LM, Parikh RC, Sireci AN, …
… nearly every therapeutic area to help commercialize your products. Located in the US, UK, Germany, Spain, and Sweden , … the economic value of your pharmaceutical and medical products. Expertise for Every Product Lifecycle Stage You …
… Pharmacoepidemiology Research Team The safety of medical products when used in pregnancy is often not well … VAC4EU and the SIGMA consortia . We have also taken the role of research site analyzing data and providing …
Collaborative Regulatory RWE Research Through our Barcelona based team, we are a partner center of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is led by the European Medicines Agency. We are dedicated to …